Dr Lawrence Ng Cheng Kiat

Dr. Ng’s academic journey began with his graduation from National University of Malaysia. He enhanced his professional credentials by obtaining membership with Royal College of Physicians, London, UK. Dr. Ng then underwent training in internal medicine and haematology under the Singhealth Residency programme, culminating in his qualification as a haematologist recognised by the Singapore Specialist Accreditation Board.

Throughout his career, Dr. Ng has developed a strong clinical interest in lymphoma. His expertise extends to bone marrow transplantation and CAR-T therapy. Additionally, Dr. Ng is passionate about geriatric haematology, a field that focuses on unique challenges of treating older adults with blood disorders.

In recognition of his dedication to advancing his knowledge and skills, Dr. Ng was awarded the HMDP grant by MOH Singapore. This grant enabled him to pursue specialized training in geriatric haematology at the esteemed Wilmot Cancer Institute, University of Rochester Medical Center, New York. During his training, he focused on targeted immunotherapy and cellular therapy in older adults with lymphoma.

As an active participant in clinical research, Dr. Ng served as a principal investigator in several Phase 2/3 lymphoma clinical trials. His research publications have focused on lymphoma, stem cell transplant, and geriatric haematology. Dr. Ng is also dedicated to education. As a Clinical Assistant Professor at Duke-NUS Medical School, he teaches and mentors undergraduate and postgraduate students

• HMDP grant - 2024
• Singhealth Long Service Awards 10 years - 2022
• Singhealth Health Quality Service HERO Awards - 2021
• Service with a Heart 2019, 2021, 2022

1. Ng, L. C. K., Lee, X. H., et al. (2025) Systematic Review and Meta Analysis: CAR-T vs Bispecific Antibody as Third or Later-line Therapy for Follicular Lymphoma. Blood Cancer Journal, 2025
2. Ng, L.C.K., Casulo, C. (2025). Current Landscape of Frontline and Relapsed Follicular Lymphoma Trials. Blood Neoplasia, Nov 2025.
3. To, H.K., Ng, L. C. K. et al (2025) A Singaporean Multi-disciplinary Team’s Quest to Deliver Precision Medicine in Older Adults with Hematological Malignancy. Journal of Geriatric Oncology, Sept 2025
4. Lee, X. H., Ang, C. H., et al., Ng, L. C. K. (2025) Prognostic Value of Geriatric Characteristic in Allogeneic Haematopoietic Stem ell Transplant Recipients Aged Over 60 Years. EJHaem, Aug 2025.
5. Ng, L. C. K., et al. (2025). Role of Geriatric Assessment in Hematopoietic Stem Cell Transplant and Cellular Therapies. Current Treatment Options in Oncology, April 10.
6. Ng, L. C. K., Ong, S. Y., Huang, X., et al. (2024). Outcome of extra-nodal follicular lymphoma affected by choice of induction chemoimmunotherapy and maintenance rituximab: A real-world retrospective study. Leukemia & Lymphoma, Dec 28, 1–7.
7. Loke, W. S. J., Catapia, J. R., et al., Ng, C. K. L. (2024) Long-term survival and clinical implications of allogeneic stem cell transplantation in relapse/refractory lymphoma: A 20-year Singapore experience. Ann Acad Med Singap. 2024 Dec 3;54(1):5-16
8. Ng, L. C. K., Tham, C., Lim, F., et al. (2021). Haematopoietic stem cell transplant in aggressive T and NK/T cell lymphoma – Role of upfront autologous transplant in nodal peripheral T-cell lymphoma. Blood Cell Therapy, 4(4), 92–100.